Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524485 · ClinicalTrials.gov registry record · NA
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00524485 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 12 participants.
The verdict
NCT00524485, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical trial is studying how well different photodynamic therapy regimens using topical aminolevulinic acid work in treating patients with actinic keratosis.
Interventions
- DRUG aminolevulinic acid
- PROCEDURE laser therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524485
The ClinicalTrials.gov registry entry for NCT00524485 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which aminolevulinic acid is the first listed.
NCT00524485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00524485 about?
NCT00524485 is a clinical study titled "Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis". RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed. Photodynamic therapy using topical aminolevulinic acid may be effective against actinic keratosis. PURPOSE: This randomized clinical tri...
What is the current status of trial NCT00524485?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2005-05. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00524485?
The interventions under investigation include: aminolevulinic acid (DRUG), laser therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00524485?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.